Study on the Association of the Polymorphism SLC2A9 rs6820230 with Gout in the Vietnamese Population
Main Article Content
Abstract
Gout is a metabolic disorder characterized by elevated uric acid levels in the blood, leading to joint inflammation and swelling in the limbs. Gout can be caused by various factors, with hereditary origins significantly contributing to the development of the disease. This study used the PCR-RFLP technique to determine the association between the SLC2A9 rs6820230 polymorphism and the risk of gout in the Vietnamese population. This study was conducted on a total of 477 samples, including 317 control samples and 160 gout samples. Statistical results show that the genotype distribution of the SLC2A9 rs6820230 polymorphism follows the Hardy-Weiberg equilibrium law with genotype frequency CC=88.49%; CT=14.47%; TT=1.05% and allele frequency C=0.917; T=0.083. In addition, we also determined that there is no association between the SLC2A9 rs6820230 polymorphism and the risk of gout in the Vietnamese population across five models, including additive, dominant, recessive, co-dominant and allelic. This study has provided more information about the influence of single nucleotide polymorphisms on the risk of gout in the Vietnamese population.
References
[2] B.L. Hainer, E. Matheson, R.T. Wilkes (2014), “Diagnosis, treatment, and prevention of gout”, Am. Fam. Physician, 90(12), pp.831–836.
[3] G. Ragab, M. Elshahaly, T. Bardin (2017), “Gout: An old disease in new perspective–A review”, J. Adv. Res., 8(5), pp.495–511.
[4] P.Q. Hung, N.X. Canh, N.T. Duong (2022), “Study on association between SLC2A9 rs3733591 and Gout susceptibility in 481 Vietnamese individuals”, Vietnam J. Sci. Technol. Eng., 64(1), pp.39–42.
[5] G. Ruiz-Heiland et al. (2016), “Novel missense mutation in the EDA gene in a family affected by oligodontia.”, J. Orofac. Orthop. Kieferorthopadie, 77(1). Accessed: Nov. 06, 2023. DOI: 10.1007/s00056-015-0005-1
[6] T. Kimura, M. Takahashi, K. Yan, H. Sakurai (2014), “Expression of SLC2A9 isoforms in the kidney and their localization in polarized epithelial cells”, PloS One, 9(1), p.e84996.
[7] J.E. Hollis‐Moffatt et al. (2009), “Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case–control sample sets”, Arthritis Rheum., 60(11), pp.3485–3492.
[8] H.-P. Tu et al. (2010), “Associations of a non-synonymous variant in SLC2A9 with gouty arthritis and uric acid levels in Han Chinese subjects and Solomon Islanders”, Ann. Rheum. Dis., 69(5), pp.887–890.
[9] N. Dalbeth et al. (2018), “Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis”, Ann. Rheum. Dis., 77(7), pp.1048–1052.
[10] O. Hurba et al. (2014), “Complex Analysis of Urate Transporters SLC2A9”, SLC22A12 Funct., . Accessed: Nov. 26, 2023. DOI:10.1371/journal.pone.0107902
[11] K. Khuancharee, C. Tanunyutthawongse, P. Sarakarn (2020), “The Combination of SLC2A9 Gene (rs2280205 and rs6820230) and Major Metabolic Factors with Association to Gout in Thai Men; A Matched Case-Control Study.”, Indian J. Public Health Res. Dev., 11(3). Accessed: Nov. 12, 2023. DOI: https://doi.org/10.37506/ijphrd.v11i3.2863
[12] S. Wannaiampikul, P. Sangsawangchot, C. Tanunyutthawongse (2020), “High prevalence of hyperuricemia and lack of association with rs2280205 and rs6820230 alleles of the SLC2A9 gene in urban Bangkok, Thailand”, Genet Mol Res, 19. Accessed: Nov. 26, 2023. DOI: http://dx.doi.org/10.4238/gmr18511
[13] A. Mancikova et al. (2016), “Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2”, Clin. Exp. Nephrol., 20(4), pp.578–584.